Name | ILIM-FARMA, OOO |
|---|
INN | 3817023970 |
|---|
KPP | 381701001 |
|---|
OGRN | 1033802009196 |
|---|
OKPO | 14462980 |
|---|
Address | 666686, Irkutskaya Oblast', g. Ust'-ilimsk, ul. Belgradskaya, d. D.8 |
|---|
Phone | +7 (395) 353-97-01 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores | | All types of activities | | 52.10 | Additional activity | Activity Warehousing and storage |
Registration date | 02.04.2003 |
|---|
Registering department | Mezhrayonnaya inspektsiya MNS Rossii N9 po Irkutskoy oblasti |
|---|
|
ILIM-FARMA, OOO (Irkutsk Oblast; INN 3817023970) was registered on 2 Apr 2003. The company's authorized capital as of July 1, 2012 was 15015 rub. Type of ownership of ILIM-FARMA, OOO - Limited liability companies. Form of ownership of ILIM-FARMA, OOO - Private property. Principal activities of ILIM-FARMA, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2023
Net profit (RAS) of ILIM-FARMA, OOO made up 2.65 million RUB over 2023 compared to net loss of 2.17 million RUB over 2022, the company informed. Revenue increased in the accounting period by 19.95% to 62.86 million RUB from 52.41 million RUB over 2022. 2022
Net loss (RAS) of ILIM-FARMA, OOO increased 1.57 times to 2.17 million RUB from 1.38 million RUB over 2021, the company informed. Revenue increased in the accounting period by 2.75% to 52.41 million RUB from 51.01 million RUB over 2021; cost of goods sold grew by 1.69% to 38.87 million RUB from 38.23 million RUB; sales loss decreased by 36.94% to 2.08 million RUB from 3.30 million RUB. 2021
Net loss (RA) of ILIM-FARMA, OOO made up 1.38 million RUB over 2021 compared to net profit of 32.00 thousand RUB over 2020, the company informed. Revenue decreased in the accounting period by 15.14% to 51.01 million RUB from 60.11 million RUB in 2020; cost of goods sold decreased by 13.66% to 38.23 million RUB from 44.28 million RUB; sales loss made up 3.30 million RUB compared to sales profit of 1.14 million RUB. 2020
Net profit (RAS) of ILIM-FARMA, OOO dropped in 2020 16.81 times to 32.00 thousand RUB from 538.00 thousand RUB over the same period in 2019, the company informed. Revenue decreased in the accounting period by 4.81% to 60.11 million RUB from 63.14 million RUB in 2019; cost of goods sold decreased by 1.87% to 44.28 million RUB from 45.12 million RUB; sales profit fell by 31.17% to 1.14 million RUB from 1.66 million RUB. 2019
Net profit (RAS) of ILIM-FARMA, OOO dropped in 2019 3.95 times to 538.00 thousand RUB from 2.13 million RUB over the same period in 2018, the company informed. Revenue decreased in the accounting period by 6.59% to 63.14 million RUB from 67.59 million RUB in 2018; cost of goods sold decreased by 6.42% to 45.12 million RUB from 48.22 million RUB; sales profit matched the previous year’s result amounting to 1.66 million RUB. 2018
Net profit (RAS) of ILIM-FARMA, OOO made up 2.13 million RUB over 2018 compared to net loss of 3.65 million RUB over 2017, the company informed. Revenue remained in the accounting period at the same level and made up 67.59 million RUB compared to 67.33 million RUB 67.33 million RUB; cost of goods sold decreased by 1.43% to 48.22 million RUB from 48.92 million RUB; sales profit made up 1.66 million RUB compared to sales loss of 1.67 million RUB. 2017
Net loss (RAS) of ILIM-FARMA, OOO increased by 22.72% to 3.65 million RUB from 2.98 million RUB over 2016, the company informed. Revenue decreased in the accounting period by 30.63% to 67.33 million RUB from 97.06 million RUB in 2016; cost of goods sold decreased by 31.88% to 48.92 million RUB from 71.81 million RUB; sales loss made up 1.67 million RUB compared to sales profit of 972.00 thousand RUB. 2016
Net loss (RAS) of ILIM-FARMA, OOO dropped over 2016 by 6.00% to 2.98 million RUB from 3.17 million RUB KAgent.Entities.Balance, the company informed. Revenue remained in the accounting period at the same level and made up 97.06 million RUB compared to 97.14 million RUB 97.14 million RUB; cost of goods sold grew by 0.75% to 71.81 million RUB from 71.28 million RUB; sales profit made up 972.00 thousand RUB compared to sales loss of 1.04 million RUB. 2014
Net loss (RAS) of Ilim-Farma, OOO increased 18.54 times to 2.17 million RUB from 117.00 thousand RUB over 2013, the company informed. Revenue increased in the accounting period by 13.66% to 95.28 million RUB from 83.83 million RUB over 2013; cost of goods sold grew by 13.89% to 69.11 million RUB from 60.68 million RUB; sales profit made up 155.00 thousand RUB compared to sales loss of 548.00 thousand RUB. 2013
Net loss (RA) of Ilim-Farma, OOO made up 117.00 thousand RUB over 2013 compared to net profit of 2.89 million RUB over 2012, the company informed. Revenue increased in the accounting period by 11.15% to 83.83 million RUB from 75.42 million RUB over 2012; cost of goods sold grew by 11.99% to 60.68 million RUB from 54.18 million RUB; sales loss made up 548.00 thousand RUB compared to sales profit of 1.59 million RUB. 2012
Net profit (RAS) of Ilim-Farma, OOO grew over 2012 3.49 times to 2.89 million RUB from 829.00 thousand RUB over 2011, the company informed. Revenue increased in the accounting period by 21.43% to 75.42 million RUB from 62.11 million RUB over 2011; cost of goods sold grew by 18.53% to 73.83 million RUB from 62.29 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|